Nutex Health (NUTX) Cash & Current Investments (2010 - 2026)

Nutex Health (NUTX) has 17 years of Cash & Current Investments data on file, last reported at $210.6 million in Q1 2026.

• Quarterly Cash & Current Investments rose 140.26% year-over-year to $210.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $210.6 million (up 140.26% YoY) and the FY2025 annual result came in at $185.9 million, up 326.5% from the prior year.
• Cash & Current Investments improved to $210.6 million in Q1 2026 per NUTX's latest filing, from $185.9 million in the prior quarter.
• The five-year high for Cash & Current Investments was $210.6 million in Q1 2026, with the low at $3.3 million in Q1 2022.
• Average Cash & Current Investments over 5 years is $67.3 million, with a median of $40.8 million recorded in 2024.
• Year-over-year, Cash & Current Investments plunged 82.64% in 2022 and jumped 909.53% in 2023.
• Nutex Health's Cash & Current Investments stood at $34.3 million in 2022, then tumbled by 35.77% to $22.0 million in 2023, then surged by 98.08% to $43.6 million in 2024, then surged by 326.5% to $185.9 million in 2025, then gained by 13.33% to $210.6 million in 2026.
• Business Quant data shows NUTX's Cash & Current Investments at $210.6 million in Q1 2026, $185.9 million in Q4 2025, and $166.0 million in Q3 2025.